Literature DB >> 20738469

Non-adherence to antibiotic prescription guidelines in treating urinary tract infection of children: a population-based study in Taiwan.

Chu C Chen1, Li C Wu, Chung Y Li, Chih K Liu, Lin C Woung, Ming C Ko.   

Abstract

OBJECTIVES: Inappropriate use of antibiotics may increase antibiotic resistance and health care service load. Few studies have been conducted to investigate physician non-adherence to antibiotic prescription guidelines for treating urinary tract infections (UTIs) in child patients. This study aimed to examine the rates of and factors associated with non-adherence to antibiotic prescription guidelines for treating uncomplicated UTIs in child patients.
METHODS: This is a cross-sectional study in which a random sample of 8921 children who received antibiotics prescription for UTIs (ICD-9-CM: 590.1, 595.0, 595.9 or 599.0) at age 17 years or less, between 2000 and 2007, were analysed. Data analysed were retrieved from Taiwan's National Health Insurance database. Non-adherence was determined by antibiotic prescription not recommended by the Infectious Disease Society of Taiwan. Multivariate logistic regression model was employed to assess the potential predictors for non-adherence, including various characteristics of patients, physicians and medical institutions.
RESULTS: The overall non-adherence rate was estimated at 20.05%. Older patients, older physicians and physicians from community clinics were associated with higher rates of non-adherence. Compared with pediatricians who had the lowest rate (13.15%) of non-adherence, certain specialties were found to have significantly elevated adjusted odds ratio (AOR) of non-adherence, with the highest one noted for gynecologists (35.11%, AOR = 2.29, 95% confidence interval: 1.89-2.77). We also observed that the most frequently prescribed antibiotics not recommended on guidelines varied with physician specialty.
CONCLUSIONS: Special attention should be concentrated on older physicians, gynecologists and physicians who practiced at community clinics to reduce non-adherence of antibiotic prescription for treating UTIs in child patients.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20738469     DOI: 10.1111/j.1365-2753.2010.01469.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  6 in total

1.  A fourfold increase of oesophageal variceal bleeding in cirrhotic patients with a history of oesophageal variceal bleeding.

Authors:  Tsung-Hsing Hung; Chih-Wei Tseng; Chih-Chun Tsai; Chorng-Jang Lay; Chen-Chi Tsai
Journal:  Singapore Med J       Date:  2015-11-25       Impact factor: 1.858

2.  The effect of infections on the mortality of cirrhotic patients with hepatic encephalopathy.

Authors:  T H Hung; C J Lay; C M Chang; J J Tsai; C C Tsai; C C Tsai
Journal:  Epidemiol Infect       Date:  2013-02-22       Impact factor: 4.434

3.  Effect of renal function impairment on the mortality of cirrhotic patients with hepatic encephalopathy: a population-based 3-year follow-up study.

Authors:  Tsung-Hsing Hung; Chih-Wei Tseng; Kuo-Chih Tseng; Yu-Hsi Hsieh; Chih-Chun Tsai; Chen-Chi Tsai
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

4.  The effect of tuberculosis on the mortality of cirrhotic patients: a population-based 3-year follow-up study.

Authors:  Tsung-Hsing Hung; Chorng-Jang Lay; Chih-Wei Tseng; Chih-Chun Tsai; Chen-Chi Tsai
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

5.  Incidence of and Predictors for Early Return Visits to the Emergency Department: A Population-Based Survey.

Authors:  Mingchung Ko; Yaling Lee; Chuchieh Chen; Pesus Chou; Dachen Chu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

6.  Effects of poor hepatic reserve in cirrhotic patients with bacterial infections: A population-based study.

Authors:  Tsung-Hsing Hung; Chih-Chun Tsai; Hsing-Feng Lee
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-02-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.